Neurorehabilitation Market Size, Share, Opportunities, And Trends By Product (Neuro-Robotic System, Wearable Devices, Brain Computer Interface, Non-Invasive Stimulators, Neuronal Prosthetics, Others), By Application (Stroke, Traumatic Brain Injury (TBI), Spinal Cord Injury (SCI), Parkinson's Disease, Cerebral Palsy, Others), By End-User (Hospitals, Clinics, Rehabilitation Centers, Home Care Settings), And By Geography - Forecasts From 2023 To 2028

The neurorehabilitation market is estimated to grow at a CAGR of 5.79% during the forecast period.

Neurorehabilitation alludes to different treatments, mediations, and hardware that are planned to advance utilitarian recuperation, reestablish versatility, and work on personal satisfaction in patients experiencing neurological illnesses or mishaps. Stroke, spinal rope injury, Parkinson's infection, different sclerosis, and different issues might be among them.

The Neurorehabilitation market size is growing quickly, attributable to an expansion in the recurrence of neurological illnesses, mechanical enhancements, and steady government endeavors. As the discipline is created, there is huge potential for extra advances in neurorehabilitation methodology and hardware, eventually prompting improved results and a better life for those with neurological impedances.

Market Drives:

• Increasing Prevalence of Neurological Disorders:

As the rate of neurological ailments like stroke, horrendous mind injury, and numerous cases of sclerosis rises, so does the interest in neurorehabilitation medicines. Market expansion is driven by the growing demand for effective rehabilitation solutions from this expanding patient population.

• Technological Advancements in Rehabilitation Devices:

Advanced rehabilitation technologies like robotic exoskeletons, brain-computer interfaces, and virtual reality systems have revolutionized neurorehabilitation. These state-of-the-art contraptions convey precise and customized treatment activities, tempting medical services experts and impelling business sector development.

• Growing Focus on Functional Recovery and Quality of Life:

There is a developing accentuation on upgrading practical recuperation and working on personal satisfaction for those with neurological infections. By providing comprehensive rehabilitation programs, neurorehabilitation plays a crucial role in achieving these goals, leading to increased demand and market expansion. 

Key Players in the Neurorehabilitation Market:

• Medtronic PLC: Medtronic is a worldwide clinical innovation supplier that gives an exhaustive scope of neurorehabilitation gear and treatments. Neurostimulation frameworks, implantable gadgets, and other new answers for the treatment of neurological ailments are important for their portfolio.
• DIH Medical Group: DIH’s subsidiary Hocoma AG manufactures sensor-based neurorehabilitation systems. Automated treatment frameworks, augmented reality stages, and sensor-helped restoration gear for upper and lower appendage recovery are among their contributions.
• Saebo Inc.: Saebo is a company that specializes in upper limb rehabilitation equipment and solutions. They provide several goods, including functional orthoses and robotic treatment systems, to help people with neurological problems improve their hand and arm function.

North America is anticipated to hold a considerable neurorehabilitation market share.

North America is projected to account for a significant market share which is attributable to various factors. Firstly, the region contains sophisticated healthcare infrastructure, such as specialized rehabilitation centers and research organizations, which encourage the use of neurorehabilitation technology. Also, neurological illnesses are common in North America, increasing the requirement for appropriate rehabilitation methods. Furthermore, favorable reimbursement regulations and government activities promoting neurorehabilitation contribute to the region's neurorehabilitation market share. Furthermore, the presence of significant companies in North America, as well as continuing expenditures in research and development operations, reinforce its market position in the Neurorehabilitation market.

Key Developments:

• In February 2023, Lupin Limited launched the first-of-its-kind computer and robotic-assisted Neurorehabilitation Center “Atharv Ability” in Mumbai. The center would provide rehabilitation programs for patients suffering from spinal cord & brain injury and other neurological conditions such as Parkinson's, multiple sclerosis, and cerebral palsy.

Neurorehabilitation Market Scope:

 

Report Metric	Details
Growth Rate	CAGR of 5.79% from 2021 to 2028
Base Year	2021
Forecast Period	2023 – 2028
Forecast Unit (Value)	USD Billion
Segments Covered	Product, Application, End-User, and Geography
Regions Covered	North America, South America, Europe, Middle East and Africa, Asia Pacific
Companies Covered	Medtronic plc, Abbott Laboratories, Bionik Laboratories Corp., Ekso Bionics Holdings, Inc., DIH Medical Group, ReWalk Robotics, BioXtreme Ltd., Kinova, Saebo Inc.
Customization Scope	Free report customization with purchase

 

Segmentation

• BY PRODUCT
  • Neuro-Robotic System
  • Wearable Devices
  • Brain Computer Interface
  • Non-Invasive Stimulators
  • Neuronal Prosthetics
  • Others     
• BY APPLICATION
  • Stroke
  • Traumatic Brain Injury (TBI)
  • Spinal Cord Injury (SCI)
  • Parkinson's Disease
  • Cerebral Palsy
  • Others   
• BY END-USER
  • Hospitals
  • Clinics
  • Rehabilitation Centers
  • Home Care Settings    
• BY Geography
  • North America
    • United States
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain    
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Others
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Indonesia
    • Taiwan
    • Others

---

1. INTRODUCTION

1.1. Market Overview

1.2. Market Definition

1.3. Scope of the Study

1.4. Market Segmentation

1.5. Currency

1.6. Assumptions

1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY  

2.1. Research Data

2.2. Research Process

3. EXECUTIVE SUMMARY

3.1. Research Highlights

4. MARKET DYNAMICS

4.1. Market Drivers

4.2. Market Restraints

4.3. Market Opportunities

4.4. Porter’s Five Force Analysis

4.4.1. Bargaining Power of Suppliers

4.4.2. Bargaining Power of Buyers

4.4.3. Threat of New Entrants

4.4.4. Threat of Substitutes

4.4.5. Competitive Rivalry in the Industry

4.5. Industry Value Chain Analysis

5. NEUROREHABILITATION MARKET BY PRODUCT

5.1. Introduction

5.2. Neuro-Robotic System

5.3. Wearable Devices

5.4. Brain-Computer Interface

5.5. Non-Invasive Simulators

5.6. Neuronal Prosthetics

5.7. Others

6. NEUROREHABILITATION MARKET BY APPLICATION

6.1. Introduction

6.2. Stroke

6.3. Traumatic Brain Injury (TBI)

6.4. Spinal Cord Injury (SCI)

6.5. Parkinson’s Disease

6.6. Cerebral Palsy

6.7. Others

7. NEUROREHABILITATION MARKET BY END-USER

7.1. Introduction

7.2. Hospitals

7.3. Clinics

7.4. Rehabilitation Centers

7.5. Home Care Settings 

8. NEUROREHABILITATION  MARKET BY GEOGRAPHY

8.1. Introduction

8.2. North America

8.2.1. United States

8.2.2. Canada

8.2.3. Mexico

8.3. South America

8.3.1.  Brazil

8.3.2. Argentina

8.3.3. Others

8.4. Europe

8.4.1. United Kingdom

8.4.2. Germany

8.4.3. France

8.4.4. Italy

8.4.5. Spain

8.4.6. Others

8.5. Middle East and Africa

8.5.1. Saudi Arabia

8.5.2. UAE

8.5.3. Others

8.6. Asia Pacific

8.6.1. Japan

8.6.2. China

8.6.3. India 

8.6.4. South Korea

8.6.5. Indonesia

8.6.6. Taiwan

8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

9.1. Major Players and Strategy Analysis

9.2. Market Share Analysis

9.3. Mergers, Acquisitions, Agreements, and Collaborations

10. COMPANY PROFILES

10.1. Medtronic PLC

10.2. Abbott Laboratories

10.3. BIONIK 

10.4. Ekso Bionics Holdings Inc.

10.5. DIH Medical Group

10.6. ReWalk Robotics

10.7. BioXtreme Ltd.

10.8. Kinova

10.9. Saebo Inc. 

Medtronic plc

Abbott Laboratories

Bionik Laboratories Corp.

Ekso Bionics Holdings, Inc.

DIH Medical Group

ReWalk Robotics

BioXtreme Ltd.

Kinova

Saebo Inc.